(R,R)-Hymeglusin

(R,R)-Hymeglusin

Chemicals & Biochemicals

Article No

AG-CN2-0103-MM25

Size

2.5 mg

Shipping Information

RT

Article No

AG-CN2-0103-MM25

Size

2.5 mg

Shipping Information

RT

Specifications

CAS No 29066-42-0
MW 324.4
Article No AG-CN2-0103-MM25
Country Availability SE, FI, DK, NO, IS, EE, LV, LT
Description (R,R)-Hymeglusin
Supplier Adipogen Life Sciences
Format Powder
Notes beta-Lactone antibiotic [1]. Antibacterial and antifungal [1, 4]. Specific and irreversible inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase in vitro and in vivo by covalently modifying the active Cys129 residue of the enzyme [2-4, 6-8]. Mevalonate biosynthesis inhibitor [5].|Chemical. CAS: 29066-42-0. Formula: C18H28O5. MW: 324.4. Isolated from fungal strain Scopulariopsis sp. F-244. beta-Lactone antibiotic. Antibacterial and antifungal. Specific and irreversible inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase in vitro and in vivo by covalently modifying the active Cys129 residue of the enzyme. Mevalonate biosynthesis inhibitor.
Molecular Formula C18H28O5
Alias Names 1233A; F-244; L-659-699
Product Type Chemicals & Biochemicals
Purity >95%
Research area Metabolism
Shipping Information RT
Size 2.5 mg
Solubility Soluble in methanol, ethanol, DMSO, chloroform or ethyl acetate. Insoluble in water or hexane.
Stability Stable for at least 3 years after receipt when stored at -20°C.
Storage -20°C, 4°C
Technical Specifications Chemical. CAS: 29066-42-0. Formula: C18H28O5. MW: 324.4. Isolated from fungal strain Scopulariopsis sp. F-244. beta-Lactone antibiotic. Antibacterial and antifungal. Specific and irreversible inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase in vitro and in vivo by covalently modifying the active Cys129 residue of the enzyme. Mevalonate biosynthesis inhibitor.
Product Page Updated 2024-02-01T08:25:01.492Z

Product images

Documentation

References

Show more
Shipping info
The delivery time for this item is approximately 5-8 business days. Read more